While CCR1-CCL4 has distinct correlation to survival depending on the cancer type considered, CCR5-CCL7 or CCR5-CCL8 co-upregulation is always associated with higher survival, suggesting a general anti-tumor immunity of these axes in the specific cancer subtypes (Figure 4E). This evidence concerns the gene CCR5 and neoplasm.